Microvascular complications and diabetic retinopathy: recent advances and future implications
- 1 March 2013
- journal article
- review article
- Published by Future Science Ltd in Future Medicinal Chemistry
- Vol. 5 (3), 301-314
- https://doi.org/10.4155/fmc.12.206
Abstract
Retinal microvascular alterations have been observed during diabetic retinopathy (DR) due to the retinal susceptibility towards subtle pathological alterations. Therefore, retinal microvascular pathology is essential to understand the nature of retinal degenerations during DR. In this review, the role of retinal microvasculature complications during progression of DR, along with recent efforts to normalize such alterations for better therapeutic outcome, will be underlined. In addition, current therapeutics and future directions for advancement of standard treatment for DR patients will be discussed.Keywords
This publication has 124 references indexed in Scilit:
- Selective Blockade of Cytoskeletal Actin Remodeling Reduces Experimental Choroidal NeovascularizationInvestigative Ophthalmology & Visual Science, 2011
- Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunctionLaboratory Investigation, 2010
- Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathyNature Medicine, 2009
- Inhibition of angiogenesis in vitro: A central role for β-actin dependent cytoskeletal remodelingMicrovascular Research, 2009
- Anti‐angiogenic and vascular disrupting effects of C9, a new microtubule‐depolymerizing agentBritish Journal of Pharmacology, 2009
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular EdemaOphthalmology, 2008
- A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular EdemaOphthalmology, 2007
- Oxidative Stress and Diabetic RetinopathyExperimental Diabetes Research, 2007
- Diabetes Downregulates Large-Conductance Ca 2+ -Activated Potassium β1 Channel Subunit in Retinal Arteriolar Smooth MuscleCirculation Research, 2007
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyOphthalmology, 2006